Navigation Links
Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
Date:12/20/2010

drug candidates, uncertainty of market acceptance of Regeneron's product and drug candidates, unanticipated expenses, the availability and cost of capital, the costs of developing, producing, and selling products, the potential for any license or collaboration agreement, including Regeneron's agreements with Astellas, the sanofi-aventis Group and Bayer HealthCare, to be canceled or terminated without any product success, and risks associated with third party intellectual property.  A more complete description of these and other material risks can be found in Regeneron's filings with the United States Securities and Exchange Commission (SEC), including its Form 10-K for the year ended December 31, 2009 and Form 10-Q for the quarter ended September 30, 2010. Regeneron does not undertake any obligation to update publicly any forward-looking statement, whether as a result of new information, future events, or otherwise, unless required by law.

Bayer Forward-Looking StatementsThis release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management.  Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here.  These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com.  The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Your Contact at Bayer:Doreen Schroeder, Tel. +49 30 468-11399E-Mail: doreen.schroeder@bayer.com Your Investor Relations Contact at Regeneron:Michael Aberman, M.D. Tel. +1 (914) 345-7799E-Mail: michael.aberma
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
2. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
3. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
4. Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference
5. Regeneron Reports Third Quarter 2009 Financial and Operating Results
6. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
7. Regeneron Announces Presentation at the Deutsche Bank 2009 Biotech Boston Confab
8. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
9. Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Conference
10. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
11. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014  Decision Resources Group ... the United States will increase to a ... be primarily driven by expansion in the large direct ... devices will be increasingly adopted due to the advantages ... Other key findings from Decision Resources Group,s coverage ...
(Date:12/19/2014)... , Dec. 18, 2014 Since last month,s ... site now known as the leading online black market ... explosive growth in its offering of drugs and other ... show the takedowns did succeed in lowering the numbers ... review of the markets in August. But some new ...
(Date:12/17/2014)... and SAN DIEGO , Dec. ... PHG ; AEX: PHIA) and Volcano Corporation (NASDAQ: ... measurement solutions for cardiovascular applications, today announced that they have ... Philips will commence a tender offer to acquire all of ... per share, or a total equity purchase price of USD ...
Breaking Medicine Technology:U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8
... throughout cities nationally, LOS ANGELES and ... a wholly owned subsidiary of SpineMark Corporation, ... to create the,nation,s first multidisciplinary, multisite Spine ... spine experts under one organization.,The SpineMark SROs ...
... present interim results of the Cethrin(R) Phase ... HOPKINTON, Mass., April 9, 2008 Alseres,Pharmaceuticals, Inc. (Nasdaq: ... Dr.,Mark Hurtt, Chief Medical Officer, will discuss the CETHRIN ... Spinal Cord Injury Research,during a congressional briefing on Capitol ...
Cached Medicine Technology:SpineMark Partners With Regional Spine Leaders to Launch Its First Multisite Spine Research Organizations in Los Angeles, Denver 2SpineMark Partners With Regional Spine Leaders to Launch Its First Multisite Spine Research Organizations in Los Angeles, Denver 3Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008 2Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008 3Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008 4
(Date:12/20/2014)... 20, 2014 Xarelto bleeding lawsuits ... uncontrollable bleeding and other serious side effects will ... of Louisiana for coordinated pretrial proceedings, Wright & Schulte ... (JPML) issued an order Friday to transfer 21 Xarelto ... 22 federal courts to the Louisiana district court for ...
(Date:12/20/2014)... Today, Balfleet.com, one of the most outstanding ... 50%-70% off on its Mother of the Bride ... of the bride dresses from Balfleet.com feature gorgeous looks ... and takes pride in providing high quality dresses to ... great discounts on our mother of the bride dresses, ...
(Date:12/19/2014)... December 20, 2014 Sweetdressy.com , ... has introduced its newest selection of cheap prom dresses ... very popular in the world and clients can buy ... Meanwhile, these prom dresses feature cool cuts and delicate ... now, targeting the middle-end market. Discount shipping costs are ...
(Date:12/19/2014)... Anaheim, CA (PRWEB) December 19, 2014 ... not-for-profit corporation dedicated to developing educational events, tools ... and Rouxbe Cooking School , the world’s ... develop the prescription every human being needs: Culinary ... and plant-based cooking course, Culinary Rx, scheduled for ...
(Date:12/19/2014)... Eufaula, Oklahoma, located just 9 miles ... state’s largest lake with more than 600 miles of ... a little more than 3,000 residents, hosted its annual ... 6th of December. , Featuring Santa, Christmas lights and ... on Main Street. Narconon Arrowhead’s parade float participated ...
Breaking Medicine News(10 mins):Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 2Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 3Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 4Health News:Balfleet.com is Offering 50%-70% Off of its Mother of the Bride Dresses 2Health News:Cheap Prom Dresses Online Now at Sweetdressy.com 2Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 2Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 3Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 4Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3
... could produce treatments to reduce cravings, expand calorie burn ... that breaks down and suppresses an appetite stimulant produced ... with The Scripps Research Institute say the antibody catalyst, ... curbed their eating even after the rodents went 24 ...
... Day Bond Referendum to,Support Water, Sewage Systems, ... pointed to a report issued today that measures ... sewer infrastructure and,warns of an impending crisis unless ... systems., The report, compiled by the Sustainable ...
... Physical therapy is a cost-effective form of ... Oct. 31 Patients with,diabetes who participate ... resistance exercise demonstrate improvements in glucose control,physical ... a study,published in the November 2008 issue ...
... Nutrition 21, Inc.,(Nasdaq: NXXI ), a developer and ... levels, improve cardiovascular health,enhance memory and address chronic joint ... opening of the market -- on Thursday,November 13, 2008 ... 30, 2008. The Company has scheduled a conference call ...
... people thought certain illnesses were more dangerous if publicized ... greatly influences how people perceive the threat of infectious ... receive extensive coverage are likely to be regarded as ... the case. , "The media tend to focus on ...
... Blue Cross Blue Shield of Michigan has,closed its Detroit-based ... morning., The closings affect Blue Cross buildings on ... Service Center,buildings. The company,s office building on Jefferson Avenue ... in the impacted facilities are,being sent home for the ...
Cached Medicine News:Health News:Scientists Develop New Strategy to Fight Obesity 2Health News:Governor's Task Force Cites PA's $36.5 Billion Water Infrastructure Need; Report Underscores Call for Additional Investments 2Health News:Governor's Task Force Cites PA's $36.5 Billion Water Infrastructure Need; Report Underscores Call for Additional Investments 3Health News:New Research Shows That Combining Aerobic Exercise With High-Force Eccentric Resistance Training Improves Glucose Control in Diabetes Patients 2Health News:New Research Shows That Combining Aerobic Exercise With High-Force Eccentric Resistance Training Improves Glucose Control in Diabetes Patients 3Health News:Nutrition 21 to Report Preliminary First Quarter Fiscal Year 2009 Financial Results on Thursday, November 13, 2008 2Health News:Media Affects Public Perception of Infectious Diseases 2
... Guglielmi Detachable Coil is intended for: embolization ... of,their morphology, their location, or the patient's ... the treating,neurosurgical team to be a) very ... techniques, or b) inoperable.,The GDC is also ...
Designed to have a shock-absorbing force, providing less bounce or wasted force....
Slightly curved Periosteal elevator....
Set of 5 large bone curettes. One each of the following: angled small, straight small, angled medium, straight medium, and angled large....
Medicine Products: